Stuart L. Dombey
Gründer bei QuatRx Pharmaceuticals Co.
Aktive Positionen von Stuart L. Dombey
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
QuatRx Pharmaceuticals Co.
 QuatRx Pharmaceuticals Co. Pharmaceuticals: MajorHealth Technology QuatRx Pharmaceuticals Co. manufactures and develops therapeutic compounds. Its clinical products, ospemifene and fispemifene, treat hormone deficiencies that result from aging in women and men. The firm's preclinical program is designed to address sex steroid dependent diseases through inhibition of 17beta- hydroxysteroid dehydrogenase (HSD) enzymes. The company was founded by Robert Zerbe, Christopher Nicholas, and Stuart Dombey on November 20 2000 and is headquartered in Ann Arbor, MI. | Technik-/Wissenschafts-/F&E-Leiter | 20.11.2000 | - |
| Gründer | 20.11.2000 | - |
Karriereverlauf von Stuart L. Dombey
Ehemalige bekannte Positionen von Stuart L. Dombey
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| Squibb Corp. | General Counsel | - | - |
| Hoechst UK Ltd. | Corporate Officer/Principal | - | - |
Parke-Davis & Co. Ltd.
 Parke-Davis & Co. Ltd. Pharmaceuticals: MajorHealth Technology Part of Pfizer Inc., Parke-Davis & Co. Ltd. is a British pharmaceutical company. The company is based in St. Helier, UK. | General Counsel | 01.01.1990 | - |
Ausbildung von Stuart L. Dombey
| The University of Liverpool | Graduate Degree |
Statistik
International
| Vereinigtes Königreich | 4 |
| Vereinigte Staaten | 3 |
Operativ
| General Counsel | 2 |
| Chief Tech/Sci/R&D Officer | 1 |
| Founder | 1 |
Sektoral
| Health Technology | 4 |
| Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
QuatRx Pharmaceuticals Co.
QuatRx Pharmaceuticals Co. Pharmaceuticals: MajorHealth Technology QuatRx Pharmaceuticals Co. manufactures and develops therapeutic compounds. Its clinical products, ospemifene and fispemifene, treat hormone deficiencies that result from aging in women and men. The firm's preclinical program is designed to address sex steroid dependent diseases through inhibition of 17beta- hydroxysteroid dehydrogenase (HSD) enzymes. The company was founded by Robert Zerbe, Christopher Nicholas, and Stuart Dombey on November 20 2000 and is headquartered in Ann Arbor, MI. | Health Technology |
Parke-Davis & Co. Ltd.
Parke-Davis & Co. Ltd. Pharmaceuticals: MajorHealth Technology Part of Pfizer Inc., Parke-Davis & Co. Ltd. is a British pharmaceutical company. The company is based in St. Helier, UK. | Health Technology |
| Squibb Corp. | Health Technology |
| Hoechst UK Ltd. |
- Börse
- Insiders
- Stuart L. Dombey
- Erfahrung
